RxDoctor Payments Data

Julie Grundberg, DPM

Podiatrist · West Des Moines, IANPI 1417911827

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Stryker at 52.9% of the total.

$4,567in general payments, 2019–2025

Across 98 payments — averaging $46.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Zimmer Biomet$1K
  • Acera Surgical, Inc.$355
  • Kerecis Limited$223
  • Orthofix Medical, Inc.$82
  • Musculoskeletal Transplant Foundation Inc.$78
  • plus $301 from 6 others

What the payments were for

  • Food & beverage$4,567100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,567 in reported general payments places this provider in the 70th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$124,212
Medicare patients
541
Services billed
4,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LyricaPregabalin11$6,577
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort28$1,250
Ciclopirox41$1,222
Gabapentin106$1,180
Doxycycline Monohydrate59$754
Pregabalin26$411
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$382
Duloxetine Hcl11$324
Cephalexin27$240
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$231
Clindamycin Hcl22$230
Nabumetone11$222
Mupirocin29$214
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim35$212
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$207

Paid to pharmacies, not to this prescriber.

Other podiatrist in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →